Top Markets
#1 MowCat MowCat +48.95%
#2 Bermuda Shorts Bermuda Shorts +25.87%
#3 Velvet Velvet +24.42%
#4 Audiera Audiera +22.52%
#5 aPriori aPriori +20.79%
#6 Derive Derive +20.37%
#7 Biconomy Biconomy +18.03%
#8 Quack AI Quack AI +17.31%
#9 Geodnet Geodnet +11.94%
#10 Palladium Network Palladium Network +10.99%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Rang in Aktien #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Aktienkurs
$3.45
Zuletzt synchronisiert: 2021-09-21
Marktkapitalisierung
$4.29M
Veränderung (1 Tag)
2.07%
Veränderung (1 Jahr)
0.00%
Land
US
Handel AzurRx BioPharma, Inc. (AZRX)

Kategorie

Healthcare
Kursverlauf für AzurRx BioPharma, Inc. (AZRX)
Höchster Schlusskurs: $5.04 am 2021-09-01

Niedrigster Schlusskurs: $50.52 am 2016-10-01
Kursverlauf der Aktie von AzurRx BioPharma, Inc. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE